tiprankstipranks
Trending News
More News >
Cyfuse Biomedical K.K. (JP:4892)
:4892
Japanese Market

Cyfuse Biomedical K.K. (4892) Financial Statements

Compare
0 Followers

Cyfuse Biomedical K.K. Financial Overview

Cyfuse Biomedical K.K.'s market cap is currently ¥5.78B. The company's EPS TTM is ¥-25.83; its P/E ratio is -6.01; Cyfuse Biomedical K.K. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 54.45M¥ 61.11M¥ 374.48M¥ 708.25M¥ 137.48M
Gross Profit¥ 16.45M¥ 37.74M¥ 241.50M¥ 570.60M¥ 67.02M
Operating Income¥ -896.13M¥ -697.44M¥ -425.09M¥ 70.57M¥ -372.13M
EBITDA¥ -824.22M¥ -538.29M¥ -410.21M¥ 168.65M¥ -288.66M
Net Income¥ -872.24M¥ -589.21M¥ -473.96M¥ 142.91M¥ -329.50M
Balance Sheet
Cash & Short-Term Investments¥ 3.05B¥ 3.87B¥ 4.44B¥ 2.41B¥ 2.07B
Total Assets¥ 3.52B¥ 4.21B¥ 4.82B¥ 2.65B¥ 2.20B
Total Debt¥ 852.00M¥ 913.00M¥ 908.14M¥ 569.06M¥ 529.54M
Net Debt¥ -2.20B¥ -2.96B¥ -3.53B¥ -1.84B¥ -1.54B
Total Liabilities¥ 975.60M¥ 1.01B¥ 1.05B¥ 746.12M¥ 646.75M
Stockholders' Equity¥ 2.54B¥ 3.20B¥ 3.77B¥ 1.90B¥ 1.55B
Cash Flow
Free Cash Flow¥ -769.10M¥ -581.77M¥ -631.87M¥ 161.54M¥ -294.26M
Operating Cash Flow¥ -760.55M¥ -562.30M¥ -403.60M¥ 161.54M¥ -294.00M
Investing Cash Flow¥ -8.64M¥ -19.47M¥ -430.67M¥ -50.58M¥ -264.00K
Financing Cash Flow¥ -52.01M¥ 18.24M¥ 2.66B¥ 229.21M¥ 488.90M
Currency in JPY

Cyfuse Biomedical K.K. Earnings and Revenue History

Cyfuse Biomedical K.K. Debt to Assets

Cyfuse Biomedical K.K. Cash Flow

Cyfuse Biomedical K.K. Forecast EPS vs Actual EPS